Biotechnology
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The shot, called Arexvy, […]
Read More
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck’s Keytruda improved survival and showed long-lasting efficacy in a midstage study in patients with a deadly form of skin cancer. […]
Read More
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the company’s second-ever product to enter the U.S. market. The decision is a win for Moderna, which desperately needs another revenue source amid […]
Read More
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment for the condition. The company’s medicine helped patients live longer without seeing their cancer progress, and most people experienced that benefit for […]
Read More
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The supply tracker could be a valuable tool for many Americans scrambling to get their hands […]
Read More
Two CVS retail stores in Rhode Island join new national pharmacy union
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on February 7, 2024. Patrick T. Fallon | AFP | Getty Images Pharmacy staff at two CVS retail stores in Rhode Island voted to join a new national pharmacy union on Friday, signaling growing momentum in […]
Read More
Here’s how U.S. health officials are responding to bird flu in humans after second case
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low. A strain of bird flu called H5N1 has been confirmed […]
Read More
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana to boost supply of its highly popular weight loss drug Zepbound, diabetes treatment […]
Read More
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to rebound from the rapid decline of its Covid business. The announcement is in addition […]
Read More
FDA approves Amgen’s treatment for most deadly form of lung cancer
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly form of lung cancer. The agency cleared the drug, which will be marketed under the name Imdelltra, as a second or later line of treatment […]
Read More